Literature DB >> 6129967

Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro.

A L Mueller, T V Dunwiddie.   

Abstract

The ability of l-norepinephrine to influence epileptiform activity was examined in an in vitro rat hippocampal slice preparation. Exogenously applied norepinephrine (NE) had anticonvulsant properties in that it slowed or stopped spontaneous interictal discharges which had been initiated by superfusion of slices with medium containing penicillin and elevated levels of potassium. This anticonvulsant property of NE was shared by the alpha receptor agonists 6-fluoro-norepinephrine, l-alpha-methyl-norepinephrine, and clonidine, but not by d-alpha-methyl-norepinephrine or l-phenylephrine. The beta receptor agonists 2-fluoro-norepinephrine and l-isoproterenol, on the other hand, were proconvulsant in that they increased interictal discharge rate. The alpha receptor antagonist phentolamine selectively blocked anticonvulsant responses, whereas the beta receptor antagonist timolol selectively blocked proconvulsant activity. These results suggest that activation of alpha or beta receptors has opposing inhibitory or excitatory effects respectively on epileptiform discharges in the rat hippocampus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129967     DOI: 10.1111/j.1528-1157.1983.tb04866.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

Review 1.  Stress and Seizures: Space, Time and Hippocampal Circuits.

Authors:  B G Gunn; T Z Baram
Journal:  Trends Neurosci       Date:  2017-09-12       Impact factor: 13.837

Review 2.  Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction.

Authors:  Linda Hildegard Bergersen
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

3.  Effect of catecholaminergic drugs on quinolinate- and kynurenine-induced seizures in mice.

Authors:  I P Lapin; I V Ryzov
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

5.  Norepinephrine homogeneously inhibits alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate- (AMPAR-) mediated currents in all layers of the temporal cortex of the rat.

Authors:  Lu Dinh; Tram Nguyen; Humberto Salgado; Marco Atzori
Journal:  Neurochem Res       Date:  2009-04-09       Impact factor: 3.996

6.  A bicuculline-resistant inhibitory post-synaptic potential in rat hippocampal pyramidal cells in vitro.

Authors:  N R Newberry; R A Nicoll
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

7.  Diphenytoin, riluzole and lidocaine: three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity.

Authors:  Lihong Diao; Jennifer L Hellier; Jessica Uskert-Newsom; Philip A Williams; Kevin J Staley; Audrey S Yee
Journal:  Neuropharmacology       Date:  2013-05-21       Impact factor: 5.250

8.  Decrease of extracellular catecholamine content in the vicinity of cortical penicillin-induced epileptogenic focus: voltammetric study in the rat.

Authors:  J Pavlásek; P Mares; M Haburcák; C Masánová
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  Local anaesthetic actions of cocaine: effects on excitatory and inhibitory synaptic responses in the hippocampus in vitro.

Authors:  T V Dunwiddie; W R Proctor; J Tyma
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

10.  Electrocerebral Signature of Cardiac Death.

Authors:  Adu L Matory; Ayham Alkhachroum; Wei-Ting Chiu; Andrey Eliseyev; Kevin Doyle; Benjamin Rohaut; Jennifer A Egbebike; Angela G Velazquez; Caroline Der-Nigoghossian; Lucy Paniker; Kenneth M Prager; Sachin Agarwal; David Roh; Soojin Park; Jan Claassen
Journal:  Neurocrit Care       Date:  2021-06-28       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.